Riverwood Capital

India’s largest asset management company, SBI Funds Management, has formally moved its long-anticipated public listing plans into execution mode by appointing a consortium of nine domestic and global investment banks for a proposed IPO that could raise USD 1.4 billion (~INR 12,630 crore) in the first half of 2026. According to a report, the company […]

Hindustan Laboratories, a Maharashtra-based pharmaceutical manufacturer specializing in generic formulations for government institutions, has submitted a DRHP with the Securities and Exchange Board of India (SEBI). The company plans to raise funds through a combination of a fresh issue and offer for sale, aggregating up to 14.1 million equity shares. Hindustan Laboratories IPO: Offer Overview

Defrail Technologies IPO Description – Incorporated in 2023, Defrail Technologies is engaged in the manufacturing of rubber parts and components, including Rubber Hose and Assemblies, Rubber Profiles and Beadings, and Rubber Moulded Parts. Its products find application across automotive, railways, defence, industrial, and construction sectors. The company primarily operates on a B2B model, with a significant

Avana Electrosystems IPO Description – Avana Electrosystems operates in the power systems equipment segment, with a focused presence in the design, manufacture and supply of control and relay panels and protection relays for electricity transmission and distribution networks. The company manufactures customised Control and Relay Panels ranging from 11 kV to 220 kV for transmission lines,

GRE Renew Enertech IPO Description – Incorporated in 2008, GRE Renew Enertech is a Gujarat-based renewable energy solutions provider with a strong focus on solar power systems for industrial and commercial applications. Over more than two decades of operations, GRE Renew Enertech has evolved from an electrical and electronic components business into a diversified player in

Corona Remedies delivered a strong financial performance in the second quarter and first half of FY26, reinforcing its position as one of the fastest-growing domestic branded pharmaceutical companies in India. Corona Remedies Q2 FY26 results mark the company’s first full earnings announcement after its successful stock market listing in December 2025. Corona Remedies Q2 FY26

CIEL HR Services, a Bengaluru-headquartered human resources solutions provider, has generated strong pre-IPO momentum by raising INR 30 crore through a private placement ahead of its proposed initial public offering. The transaction, completed at an issue price of INR 110 per share, values the company at over INR 800 crore, underscoring growing institutional and strategic